[Evaluation of BED-CEIA assay with dried blood spot specimens in China]. 2009

Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

OBJECTIVE; To study the feasibility of using dried blood spot (DBS) specimens in BED-CEIA assay and to estimate the HIV-1 incidence with DBS in China. METHODS 10 313 participants from 27 voluntary counseling and testing (VCT) sites were enrolled in this study. Both plasma and DBS specimens were collected. 349 eligible pairs of HIV-1 positive specimens confirmed by Western Blot were available for BED-CEIA and the results compared. Negative control, low positive control, high positive control and calibrator in DBS were used to evaluate the stability and repeatability of the detection results of DBS specimens. RESULTS Of the total HIV positives, 294 and 53 participants were tested as long-term or recent HIV infections by both DBS and plasma specimens. Two participants showed different results from DBS and plasma specimens, but their final An values were close to the cutoff value of BED-CEIA assay. The concordance rate between the two types of specimens was 99.43% and the R2 linear of the stability and repeatability results of DBS specimens reached 0.9551 and 0.95, respectively. CONCLUSIONS Although some individual specimens showed different results, the incidence rates calculated from both types of specimen were equivalent. DBS specimens were suitable for estimating the HIV incidence and could be popularized in China. However, further studies regarding window period and adjustment coefficients of BED-CEIA assay are needed.

UI MeSH Term Description Entries
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012698 Serologic Tests Diagnostic procedures involving immunoglobulin reactions. Serodiagnosis,Serologic Test,Serological Tests,Test, Serologic,Tests, Serologic,Serodiagnoses,Serological Test,Test, Serological,Tests, Serological
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D018571 Sentinel Surveillance Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort such as in a geographic area or population subgroup to estimate trends in a larger population. (From Last, Dictionary of Epidemiology, 2d ed) Sentinel Health Event,Biosurveillance Systems,Syndromic Surveillance,Biosurveillance System,Health Event, Sentinel,Surveillance, Sentinel,Surveillance, Syndromic

Related Publications

Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
January 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
April 2013, Zhonghua yi xue za zhi,
Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
October 2010, Antimicrobial agents and chemotherapy,
Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
January 2020, Practical laboratory medicine,
Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
January 2015, Current HIV research,
Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
February 1998, Clinical chemistry,
Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
May 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
April 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
March 2022, Scientific reports,
Sheng Shen, and Fei Tian, and Hua-Zhou Jiang, and Guo-Qing Sun, and Li-Feng Miao, and Xiao-Li Guo, and Yao Xiao, and Yu-Jiang Jia, and Sten H Vermund, and Yan Jiang
April 2024, Journal of virological methods,
Copied contents to your clipboard!